Olopatine Eye Drops (Olopatadine Hydrochloride)

Adult eye dose

Instill 1 drop, 2 times a day (every 6 to 8 hours). Treatment may continue for a maximum of 4 months if necessary.

This medication should not be used by patients with an allergic reaction to the active ingredient or any of the components. Use of this medication may result in neurological symptoms such as headache, taste alteration, and dizziness. Various eye-related side effects may occur, including punctate keratitis, keratitis, eye pain, dry eyes, itchy eyes, eye discharge, and eye redness. Dryness of the nose or symptoms of rhinitis may appear, and dry mouth symptoms have been reported rarely. Contact dermatitis may occur on the skin, and fatigue may also be felt. Following the use of this medication, increased sensitivity in the eyes, weakness, cold symptoms, nausea, pharyngitis, sinusitis, abdominal pain, liver function abnormalities, and increased blood pressure may also occur. This medication contains phosphate components, which may cause a rare side effect of corneal calcification in patients with severe corneal damage. Vision may temporarily become blurred after administration, so it is important to wait until vision is clear before driving or operating machinery. Patients undergoing long-term steroid treatment should reduce the steroid dosage gradually under medical supervision when using this medication. Patients with seasonal allergies should start using this medication before symptoms begin and continue until symptoms resolve. If there is no effect, it is advisable to avoid long-term use. The component benzalkonium chloride included in this medication can cause eye irritation and may discolor soft contact lenses, so contact lenses should not be worn during use. Contact lenses should be inserted at least 15 minutes after administration, and wearing them should be avoided if there is eye redness. During pregnancy, this medication should be used cautiously as its safety for the fetus has not been established, and it should be used under a doctor's supervision. Breastfeeding mothers should consult a physician before use, as this medication may be excreted in breast milk and could potentially affect the baby. The safety and efficacy of this medication in children under 3 years old have not been established, so usage should be avoided. There is no special dosage adjustment needed for the elderly. This medication should only be used locally in the eye and should not be administrated orally or by injection. Care should be taken not to let the tip of the container touch the eye directly, and the cap should be securely closed after use to prevent contamination. When using other eye drops, a minimum interval of 5 minutes should be maintained, and ointments should be administered last. Store in a place out of reach of children, avoiding direct sunlight, and keep in a cool place. Do not transfer this medication to another container, as this is important for preventing misuse and maintaining quality.

Serious side effects

• Jaundice
• urinary difficulty
• increased blood pressure

Mild side effects

• Headache
• taste alteration
• dizziness
• punctate keratitis
• keratitis
• eye pain
• dry eyes
• eyelid swelling
• itchy eyes
• eye discharge

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to maintain a temperature between 4°C and 25°C when storing the medication. This will help maintain the medication's effectiveness for a prolonged period.

Appearance

The eye drops are a colorless to pale yellow opaque liquid packaged in an opaque white plastic container.

Package unit

Bottle packaging - 6 milliliters per bottle